Liquid oxygen devices market seen reaching $8.72 billion by 2030

The Business Research Company says the liquid oxygen devices market is expanding as respiratory disease rates rise, healthcare systems add oxygen capacity, and home-based care grows. The market is projected to climb from $6.46 billion in 2025 to $8.72 billion by 2030, with North America leading and Asia-Pacific poised for the fastest growth.

Why it matters: - Liquid oxygen devices are becoming more important as respiratory illnesses rise and healthcare providers look for efficient oxygen delivery systems. - The market’s projected growth suggests more demand for hospital, acute care, and home-care respiratory support. - The report points to a shift toward long-term oxygen therapy, especially for aging populations and patients with chronic breathing conditions.

What happened: - The Business Research Company said the liquid oxygen devices market is expected to grow from $6.46 billion in 2025 to $6.91 billion in 2026. - The market is projected to reach $8.72 billion by 2030. - The forecast implies a 7.0% CAGR from 2025 to 2026 and a 6.0% CAGR from 2026 to 2030. - The company released a free sample of the report here. - The full report is available here.

The details: - Liquid oxygen devices store concentrated oxygen at about -183°C, or -297°F. - The devices are designed to provide oxygen therapy to patients who need respiratory support. - Compact storage and easier transport make liquid oxygen devices useful in both healthcare facilities and home care settings. - The report links growth to higher rates of chronic respiratory disease, more respiratory hospital admissions, expanded oxygen facilities, greater use of oxygen therapy in acute care, and better awareness of oxygen therapy benefits. - The report also cites aging populations, stronger demand for long-term oxygen therapy, broader home-based respiratory care, healthcare expansion in emerging markets, and better readiness for respiratory outbreaks as growth drivers through 2030. - The market’s expected trends include wider use for severe respiratory illness, more high-purity oxygen delivery systems in hospitals, longer-duration home care use, growth in cryogenic storage, and a preference for larger-capacity oxygen systems. - England recorded 854,922 emergency hospital admissions for respiratory diseases in fiscal 2024, up 7% from the prior year, according to Gov.UK data cited in June 2025. - The respiratory admission rate in England was 1,428 per 100,000 people, above the prior year but still below pre-pandemic levels. - Government-led healthcare research and development programs are described as another support for market growth. - IQVIA said in January 2024 that global medicine consumption rose 14% over the past five years and is projected to rise another 12% by 2028, reaching about 3.8 trillion defined daily doses annually.

Between the lines: - The market outlook reflects a broader healthcare trend: more oxygen delivery is moving outside hospitals and into home settings. - The strongest demand signal appears to come from chronic and acute respiratory disease management rather than from a single device upgrade cycle. - North America’s current lead suggests mature infrastructure and high therapy adoption are already supporting sales, while Asia-Pacific’s growth outlook points to rising access and infrastructure buildout.

What's next: - The report expects Asia-Pacific to post the fastest growth during the forecast period. - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The Business Research Company says its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis, and future trend coverage. - The company also listed contacts for expert inquiries, including Saumya Sahay and its regional phone and email details. - The company directs readers to its website and social accounts, including LinkedIn, Facebook, and X.